The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amivantamab Market Research Report 2025
Synopsis
The global Amivantamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amivantamab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amivantamab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amivantamab include ProteoGenix, Thermo Fisher Scientific, AntibodySystem SAS, Wuhan Chemstan Biotechnology and Biochempartner, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amivantamab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amivantamab.
Report Scope
The Amivantamab market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amivantamab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amivantamab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProteoGenix
Thermo Fisher Scientific
AntibodySystem SAS
Wuhan Chemstan Biotechnology
Biochempartner
Segment by Type
0 - 100ug
100ug - 1mg
Above 1mg
Segment by Application
Pharmaceutics
Clinical Testing
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amivantamab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amivantamab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Amivantamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amivantamab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amivantamab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amivantamab include ProteoGenix, Thermo Fisher Scientific, AntibodySystem SAS, Wuhan Chemstan Biotechnology and Biochempartner, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amivantamab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amivantamab.
Report Scope
The Amivantamab market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amivantamab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amivantamab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProteoGenix
Thermo Fisher Scientific
AntibodySystem SAS
Wuhan Chemstan Biotechnology
Biochempartner
Segment by Type
0 - 100ug
100ug - 1mg
Above 1mg
Segment by Application
Pharmaceutics
Clinical Testing
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amivantamab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amivantamab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amivantamab Market Overview
1.1 Product Overview and Scope of Amivantamab
1.2 Amivantamab Segment by Type
1.2.1 Global Amivantamab Market Value Comparison by Type (2024-2030)
1.2.2 0 - 100ug
1.2.3 100ug - 1mg
1.2.4 Above 1mg
1.3 Amivantamab Segment by Application
1.3.1 Global Amivantamab Market Value by Application: (2024-2030)
1.3.2 Pharmaceutics
1.3.3 Clinical Testing
1.3.4 Others
1.4 Global Amivantamab Market Size Estimates and Forecasts
1.4.1 Global Amivantamab Revenue 2019-2030
1.4.2 Global Amivantamab Sales 2019-2030
1.4.3 Global Amivantamab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amivantamab Market Competition by Manufacturers
2.1 Global Amivantamab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amivantamab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amivantamab Average Price by Manufacturers (2019-2024)
2.4 Global Amivantamab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amivantamab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amivantamab, Product Type & Application
2.7 Amivantamab Market Competitive Situation and Trends
2.7.1 Amivantamab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amivantamab Players Market Share by Revenue
2.7.3 Global Amivantamab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amivantamab Retrospective Market Scenario by Region
3.1 Global Amivantamab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amivantamab Global Amivantamab Sales by Region: 2019-2030
3.2.1 Global Amivantamab Sales by Region: 2019-2024
3.2.2 Global Amivantamab Sales by Region: 2025-2030
3.3 Global Amivantamab Global Amivantamab Revenue by Region: 2019-2030
3.3.1 Global Amivantamab Revenue by Region: 2019-2024
3.3.2 Global Amivantamab Revenue by Region: 2025-2030
3.4 North America Amivantamab Market Facts & Figures by Country
3.4.1 North America Amivantamab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amivantamab Sales by Country (2019-2030)
3.4.3 North America Amivantamab Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amivantamab Market Facts & Figures by Country
3.5.1 Europe Amivantamab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amivantamab Sales by Country (2019-2030)
3.5.3 Europe Amivantamab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amivantamab Market Facts & Figures by Country
3.6.1 Asia Pacific Amivantamab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amivantamab Sales by Country (2019-2030)
3.6.3 Asia Pacific Amivantamab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amivantamab Market Facts & Figures by Country
3.7.1 Latin America Amivantamab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amivantamab Sales by Country (2019-2030)
3.7.3 Latin America Amivantamab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Amivantamab Market Facts & Figures by Country
3.8.1 Middle East and Africa Amivantamab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amivantamab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amivantamab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amivantamab Sales by Type (2019-2030)
4.1.1 Global Amivantamab Sales by Type (2019-2024)
4.1.2 Global Amivantamab Sales by Type (2025-2030)
4.1.3 Global Amivantamab Sales Market Share by Type (2019-2030)
4.2 Global Amivantamab Revenue by Type (2019-2030)
4.2.1 Global Amivantamab Revenue by Type (2019-2024)
4.2.2 Global Amivantamab Revenue by Type (2025-2030)
4.2.3 Global Amivantamab Revenue Market Share by Type (2019-2030)
4.3 Global Amivantamab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amivantamab Sales by Application (2019-2030)
5.1.1 Global Amivantamab Sales by Application (2019-2024)
5.1.2 Global Amivantamab Sales by Application (2025-2030)
5.1.3 Global Amivantamab Sales Market Share by Application (2019-2030)
5.2 Global Amivantamab Revenue by Application (2019-2030)
5.2.1 Global Amivantamab Revenue by Application (2019-2024)
5.2.2 Global Amivantamab Revenue by Application (2025-2030)
5.2.3 Global Amivantamab Revenue Market Share by Application (2019-2030)
5.3 Global Amivantamab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ProteoGenix
6.1.1 ProteoGenix Corporation Information
6.1.2 ProteoGenix Description and Business Overview
6.1.3 ProteoGenix Amivantamab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ProteoGenix Amivantamab Product Portfolio
6.1.5 ProteoGenix Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Amivantamab Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Amivantamab Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 AntibodySystem SAS
6.3.1 AntibodySystem SAS Corporation Information
6.3.2 AntibodySystem SAS Description and Business Overview
6.3.3 AntibodySystem SAS Amivantamab Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AntibodySystem SAS Amivantamab Product Portfolio
6.3.5 AntibodySystem SAS Recent Developments/Updates
6.4 Wuhan Chemstan Biotechnology
6.4.1 Wuhan Chemstan Biotechnology Corporation Information
6.4.2 Wuhan Chemstan Biotechnology Description and Business Overview
6.4.3 Wuhan Chemstan Biotechnology Amivantamab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Chemstan Biotechnology Amivantamab Product Portfolio
6.4.5 Wuhan Chemstan Biotechnology Recent Developments/Updates
6.5 Biochempartner
6.5.1 Biochempartner Corporation Information
6.5.2 Biochempartner Description and Business Overview
6.5.3 Biochempartner Amivantamab Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biochempartner Amivantamab Product Portfolio
6.5.5 Biochempartner Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amivantamab Industry Chain Analysis
7.2 Amivantamab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amivantamab Production Mode & Process
7.4 Amivantamab Sales and Marketing
7.4.1 Amivantamab Sales Channels
7.4.2 Amivantamab Distributors
7.5 Amivantamab Customers
8 Amivantamab Market Dynamics
8.1 Amivantamab Industry Trends
8.2 Amivantamab Market Drivers
8.3 Amivantamab Market Challenges
8.4 Amivantamab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Amivantamab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amivantamab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amivantamab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amivantamab Sales (Mg) of Key Manufacturers (2019-2024)
Table 5. Global Amivantamab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amivantamab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amivantamab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amivantamab Average Price (US$/Mg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amivantamab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amivantamab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amivantamab, Product Type & Application
Table 12. Global Key Manufacturers of Amivantamab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amivantamab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amivantamab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amivantamab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amivantamab Sales by Region (2019-2024) & (Mg)
Table 18. Global Amivantamab Sales Market Share by Region (2019-2024)
Table 19. Global Amivantamab Sales by Region (2025-2030) & (Mg)
Table 20. Global Amivantamab Sales Market Share by Region (2025-2030)
Table 21. Global Amivantamab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amivantamab Revenue Market Share by Region (2019-2024)
Table 23. Global Amivantamab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amivantamab Revenue Market Share by Region (2025-2030)
Table 25. North America Amivantamab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amivantamab Sales by Country (2019-2024) & (Mg)
Table 27. North America Amivantamab Sales by Country (2025-2030) & (Mg)
Table 28. North America Amivantamab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amivantamab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amivantamab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amivantamab Sales by Country (2019-2024) & (Mg)
Table 32. Europe Amivantamab Sales by Country (2025-2030) & (Mg)
Table 33. Europe Amivantamab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amivantamab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amivantamab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amivantamab Sales by Region (2019-2024) & (Mg)
Table 37. Asia Pacific Amivantamab Sales by Region (2025-2030) & (Mg)
Table 38. Asia Pacific Amivantamab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amivantamab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amivantamab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amivantamab Sales by Country (2019-2024) & (Mg)
Table 42. Latin America Amivantamab Sales by Country (2025-2030) & (Mg)
Table 43. Latin America Amivantamab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amivantamab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amivantamab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amivantamab Sales by Country (2019-2024) & (Mg)
Table 47. Middle East & Africa Amivantamab Sales by Country (2025-2030) & (Mg)
Table 48. Middle East & Africa Amivantamab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amivantamab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amivantamab Sales (Mg) by Type (2019-2024)
Table 51. Global Amivantamab Sales (Mg) by Type (2025-2030)
Table 52. Global Amivantamab Sales Market Share by Type (2019-2024)
Table 53. Global Amivantamab Sales Market Share by Type (2025-2030)
Table 54. Global Amivantamab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amivantamab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amivantamab Revenue Market Share by Type (2019-2024)
Table 57. Global Amivantamab Revenue Market Share by Type (2025-2030)
Table 58. Global Amivantamab Price (US$/Mg) by Type (2019-2024)
Table 59. Global Amivantamab Price (US$/Mg) by Type (2025-2030)
Table 60. Global Amivantamab Sales (Mg) by Application (2019-2024)
Table 61. Global Amivantamab Sales (Mg) by Application (2025-2030)
Table 62. Global Amivantamab Sales Market Share by Application (2019-2024)
Table 63. Global Amivantamab Sales Market Share by Application (2025-2030)
Table 64. Global Amivantamab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amivantamab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amivantamab Revenue Market Share by Application (2019-2024)
Table 67. Global Amivantamab Revenue Market Share by Application (2025-2030)
Table 68. Global Amivantamab Price (US$/Mg) by Application (2019-2024)
Table 69. Global Amivantamab Price (US$/Mg) by Application (2025-2030)
Table 70. ProteoGenix Corporation Information
Table 71. ProteoGenix Description and Business Overview
Table 72. ProteoGenix Amivantamab Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 73. ProteoGenix Amivantamab Product
Table 74. ProteoGenix Recent Developments/Updates
Table 75. Thermo Fisher Scientific Corporation Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Amivantamab Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 78. Thermo Fisher Scientific Amivantamab Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. AntibodySystem SAS Corporation Information
Table 81. AntibodySystem SAS Description and Business Overview
Table 82. AntibodySystem SAS Amivantamab Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 83. AntibodySystem SAS Amivantamab Product
Table 84. AntibodySystem SAS Recent Developments/Updates
Table 85. Wuhan Chemstan Biotechnology Corporation Information
Table 86. Wuhan Chemstan Biotechnology Description and Business Overview
Table 87. Wuhan Chemstan Biotechnology Amivantamab Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 88. Wuhan Chemstan Biotechnology Amivantamab Product
Table 89. Wuhan Chemstan Biotechnology Recent Developments/Updates
Table 90. Biochempartner Corporation Information
Table 91. Biochempartner Description and Business Overview
Table 92. Biochempartner Amivantamab Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 93. Biochempartner Amivantamab Product
Table 94. Biochempartner Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Amivantamab Distributors List
Table 98. Amivantamab Customers List
Table 99. Amivantamab Market Trends
Table 100. Amivantamab Market Drivers
Table 101. Amivantamab Market Challenges
Table 102. Amivantamab Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amivantamab
Figure 2. Global Amivantamab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amivantamab Market Share by Type in 2023 & 2030
Figure 4. 0 - 100ug Product Picture
Figure 5. 100ug - 1mg Product Picture
Figure 6. Above 1mg Product Picture
Figure 7. Global Amivantamab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amivantamab Market Share by Application in 2023 & 2030
Figure 9. Pharmaceutics
Figure 10. Clinical Testing
Figure 11. Others
Figure 12. Global Amivantamab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Amivantamab Market Size (2019-2030) & (US$ Million)
Figure 14. Global Amivantamab Sales (2019-2030) & (Mg)
Figure 15. Global Amivantamab Average Price (US$/Mg) & (2019-2030)
Figure 16. Amivantamab Report Years Considered
Figure 17. Amivantamab Sales Share by Manufacturers in 2023
Figure 18. Global Amivantamab Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Amivantamab Players: Market Share by Revenue in 2023
Figure 20. Amivantamab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Amivantamab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Amivantamab Sales Market Share by Country (2019-2030)
Figure 23. North America Amivantamab Revenue Market Share by Country (2019-2030)
Figure 24. United States Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Amivantamab Sales Market Share by Country (2019-2030)
Figure 27. Europe Amivantamab Revenue Market Share by Country (2019-2030)
Figure 28. Germany Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Amivantamab Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Amivantamab Revenue Market Share by Region (2019-2030)
Figure 35. China Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Amivantamab Sales Market Share by Country (2019-2030)
Figure 45. Latin America Amivantamab Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Amivantamab Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Amivantamab Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Amivantamab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Amivantamab by Type (2019-2030)
Figure 56. Global Revenue Market Share of Amivantamab by Type (2019-2030)
Figure 57. Global Amivantamab Price (US$/Mg) by Type (2019-2030)
Figure 58. Global Sales Market Share of Amivantamab by Application (2019-2030)
Figure 59. Global Revenue Market Share of Amivantamab by Application (2019-2030)
Figure 60. Global Amivantamab Price (US$/Mg) by Application (2019-2030)
Figure 61. Amivantamab Value Chain
Figure 62. Amivantamab Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
